Literature DB >> 3492639

Multiparameter characterization of L3 leukemia cell populations.

A J Walle, A Al-Katib, G Y Wong, S C Jhanwar, R S Chaganti, B Koziner.   

Abstract

Multiparameter analysis of 14 consecutive patients with L3 cell populations (FAB classification) in bone marrow showed consistently high mean cellular RNA content but heterogeneity with respect to percent cels in S- and G2M-phases of the cell cycle, cell surface phenotype, cytogenetic abnormalities, cellular DNA content, and nuclear activities of terminal deoxynucleotidyl transferase. Five of the 14 patients had the characteristic profile of L3 leukemia with high RNA content, a typical t(8;14) or t(8;22) translocation, low Tdt, B-cell surface phenotype, pseudodiploid modal number of chromosomes, high proliferation and normal DNA index. The remaining 9 patients had features thought to be unusual and they were very heterogeneous. Median survival time from time of diagnosis was 115 days with no patient alive after 474 days. The survival times exhibited excellent correlation with a parametric model assuming exponential distribution. Accordingly, the presence of abnormal DI predicted for decreased, and the presence of t(8;14) or pseudodiploidy was associated with increased survival rates. However, due to the small number of patients in this study, generally applicable conclusions should be drawn only from a collection of larger numbers of cases of this rare type of leukemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3492639     DOI: 10.1016/0145-2126(87)90107-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  1 in total

1.  Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Authors:  Shotaro Iwamoto; Takao Deguchi; Hideaki Ohta; Nobutaka Kiyokawa; Masahito Tsurusawa; Tomomi Yamada; Kozo Takase; Junichiro Fujimoto; Ryoji Hanada; Hiroki Hori; Keizo Horibe; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2011-07-30       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.